Biological and Pharmaceutical Bulletin
The Pharmaceutical Society of Japan, established in 1880, is one of Japan’s oldest and most distinguished academic societies. The Society currently has around 18,000 members. It publishes three monthly scientific journals. Chemical and Pharmaceutical Bulletin (Chem. Pharm. Bull.) began publication in 1953 as Pharmaceutical Bulletin. It covers chemistry fields in the pharmaceutical and health sciences. Biological and Pharmaceutical Bulletin (Biol. Pharm. Bull.) began publication in 1978 as the Journal of Pharmacobio-Dynamics. It covers various biological topics in the pharmaceutical and health sciences. A fourth Society journal, the Journal of Health Science, was merged with Biol. Pharm. Bull. in 2012. Yakugaku Zasshi (Japanese for “Pharmaceutical Science Journal”) has the longest history, with publication beginning in 1881. Yakugaku Zasshi is published mostly in Japanese, except for some articles related to clinical pharmacy and pharmaceutical education, which are published in English.
The main aim of the Society’s journals is to advance the pharmaceutical sciences with research reports, information exchange, and high-quality discussion. The average review time for articles submitted to the journals is around one month for first decision. The complete texts of all of the Society’s journals can be freely accessed through J-STAGE. The Society’s editorial committee hopes that the content of its journals will be useful to your research, and also invites you to submit your own work to the journals.

Chairman of Committee
Ken-ichi Hosoya
Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama



Read more
9,614 registered articles
(updated on October 21, 2018)
Online ISSN : 1347-5215
Print ISSN : 0918-6158
1.694
2017 IMPACT FACTOR
JOURNALS PEER REVIEWED FREE ACCESS FULL-TEXT HTML ADVANCE PUBLICATION
Featured article
Volume 41 (2018) Issue 10 Pages 1567-1573
Characteristics of Bone Strength and Metabolism in Type 2 Diabetic Model Nagoya Shibata Yasuda Mice Read more
Editor’s picks

Type 2 diabetes mellitus (T2DM) animal models are often used in basic research on diabetic osteoporosis. The article by Tanaka et al. elucidated hyperglycemia contributed to a decrease in bone metabolism turnover in the T2DM animal model NSY mice, resulting in a thinner and shorter femur, lower cortical and trabecular area, and lower bone mass. Their results suggest that these effects contribute to the deteriorated bone strength of the femur in NSY mice, and the NSY mouse could serve as an appropriate T2DM animal model for examining the specific effect of hyperglycemia on bone integrity, using the ICR mouse as a control.

View the past featured articles
Most viewed articles Sep.2018
Share this page
Select past volume & issue
Journal news & Announcements
  • Biol. Pharm. Bull. Vol. 41 No. 9
    Current Topics: Recent Advances in Research on Biological Membranes That Regulate the Central Nervous System




  • Biol. Pharm. Bull. Vol. 41 No. 8
    Current Topics: Ion Channels as Therapeutic Targets for the Immune, Inflammatory, and Metabolic Disorders




  • Biol. Pharm. Bull. Vol. 41 No. 7
    Current Topics:New Insights into Neurozinc and Metallothioneins




  • Biol. Pharm. Bull. Vol. 41 No. 3
    Current Topics: Cutting-Edge Studies Using Artificial Membranes
  • Biol. Pharm. Bull. Vol. 40 No. 12
    Current Topics: Recent Progress in the Study of Vasoactive Modulators in Metabolic and Cardiovascular Diseases



feedback
Top